However, we found that high expression of VEGFR-3 was significantly higher in OSCC patients with the presence of lymph node metastasis than those without lymph node metastasis (P = 0.000). This evidence concerns the gene FLT4 and metastatic malignant neoplasm in the lymph nodes.